iBio Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details Textual)

Stockholders' Equity (Details Textual) - USD ($)						1 Months Ended										2 Months Ended	3 Months Ended
Stockholders' Equity (Details Textual) - USD ($)	Jul. 12, 2018	Apr. 13, 2016	Apr. 07, 2016	Jan. 13, 2016	May 15, 2015	Jun. 30, 2018	Jun. 26, 2018	Jun. 26, 2018	May 31, 2018	Mar. 31, 2018	Dec. 31, 2017	Nov. 30, 2017	Jul. 24, 2017	Feb. 23, 2017	Jan. 25, 2016	Aug. 31, 2018	Sep. 30, 2018	Sep. 13, 2018	Jun. 20, 2018	Dec. 19, 2017
Stockholders' Equity [Line Items]
Preferred Stock, Shares Authorized														1,000,000
Common Stock, Shares Authorized						275,000,000											275,000,000			275,000,000
Common Stock, Shares, Issued						16,040,126							120,000				18,336,792
Stock Issued During Period, Shares, New Issues	1,500,000							4,350,000				2,250,000
Stock Issued During Period, Value, New Issues							$ 16,000,000					$ 4,500,000
Share Price							$ 0.90	$ 0.90										$ 0.78
Shares Issued, Price Per Share							0.90	0.90				$ 2.00
Registration Common Stock																	$ 1,500,000
Common Stock, Par or Stated Value Per Share						$ 0.001	$ 0.90	$ 0.90									$ 0.001
Convertible Preferred Stock, Shares Issued upon Conversion							7,000,000	7,000,000								796,666	896,666
Preferred Stock, Par or Stated Value Per Share							$ 1,000	$ 1,000											$ 0.001
Offering Price To New Investors						7.00%						7.00%
Offering Price to Existing Investors						3.50%						3.50%
Underwriting Discounts, Commissions and Other Offering Expenses	$ 159,000											$ 311,000					$ 854,000
Payments to Acquire Interest in Subsidiaries and Affiliates											$ 3,500,000
Proceeds from Noncontrolling Interests									$ 1.093		$ 1.05
Conversion of Stock, Shares Converted																6,300	807
Common Stock, Capital Shares Reserved for Future Issuance																	12,500,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized								2,666,666
Common Stock [Member]
Stockholders' Equity [Line Items]
Stock Issued During Period, Shares, New Issues							4,350,000
Shares Issued, Price Per Share							$ 0.90	$ 0.90
Conversion of Stock, Shares Converted																	896,666
Preferred Stock [Member]
Stockholders' Equity [Line Items]
Preferred Stock, Shares Authorized																	1
Series A Preferred Stock [Member]
Stockholders' Equity [Line Items]
Preferred Stock, Shares Authorized						6,300											6,300		1,000,000
Stock Issued During Period, Shares, New Issues							6,300	6,300
Preferred Stock, Par or Stated Value Per Share							$ 1,000	$ 1,000											$ 0.001
Convertible Preferred Stock, Terms of Conversion																	Each share of Series A Preferred is convertible into an amount of shares of common stock determined by dividing the stated value of $1,000 by the conversion price of $0.90. The number of shares of common stock to be received is limited by the beneficial ownership limitation as defined in the certificate of designation. Subject to limited exceptions, a holder of Series A Preferred will not have the right to exercise any portion of its Series A Preferred if such holder, together with its affiliates, would beneficially own over 4.99% of the number of shares of our common stock outstanding immediately after giving effect to such exercise; provided, however, that upon 61 days’ prior notice to us, such holder may increase the such limitation, provided that in no event will the limitation exceed 9.99%.
Conversion of Stock, Shares Converted																717	807
Series B Preferred Stock [Member]
Stockholders' Equity [Line Items]
Preferred Stock, Shares Authorized						5,785											5,785		1,000,000
Stock Issued During Period, Shares, New Issues							5,785	5,785
Preferred Stock, Par or Stated Value Per Share							$ 1,000	$ 1,000
Convertible Preferred Stock, Terms of Conversion																	Each share of Series B Preferred is convertible into an amount of shares of common stock determined by dividing the stated value of $1,000 by the conversion price of $0.90. The number of shares of common stock to be received is limited by the beneficial ownership limitation as defined in the certificate of designation. Subject to limited exceptions, a holder of Series B Preferred will not have the right to exercise any portion of its Series B Preferred if such holder, together with its affiliates, would beneficially own over 48% of the number of shares of our common stock outstanding immediately after giving effect to such exercise.
Series B Preferred Stock [Member] \| Common Stock [Member]
Stockholders' Equity [Line Items]
Convertible Preferred Stock, Shares Issued upon Conversion							6,427,778	6,427,778
Stockholders [Member]
Stockholders' Equity [Line Items]
Stock Issued During Period, Shares, New Issues			650,000
Over-Allotment Option [Member]
Stockholders' Equity [Line Items]
Stock Issued During Period, Shares, New Issues	1,500,000											11,000
Stock Issued During Period, Value, New Issues								$ 17,350,000
Shares Issued, Price Per Share	$ 0.90						$ 0.90	$ 0.90
Eastern Share Purchase Agreements [Member]
Stockholders' Equity [Line Items]
Proceeds from Warrant Exercises															$ 945,000
Stock Issued During Period, Shares, New Issues		650,000		650,000				650,000
Stock Issued During Period, Value, New Issues		$ 4,043,000													$ 2,177,000
Class of Warrant or Right, Exercise Price of Warrants or Rights															$ 5.30
Stock Issued During Period, Shares, Acquisitions				350,000
Common Stock, Par or Stated Value Per Share				$ 6.22
Class Of Warrants Or Rights Exercised															178,400
Maximum Common Stock Percentage				38.00%				48.00%				38.00%
Equity Method Investment, Ownership Percentage												40.00%
Lincoln Park Purchase Agreement [Member]
Stockholders' Equity [Line Items]
Aggregate Common Stock Purchased													$ 16,000,000
Stock Issued During Period, Shares, Other													10,000
Share Price													$ 2.50
Additional Aggregate Common Stock Purchased													$ 15,000,000				$ 14,878,710
Aspire Capital Fund, LLC 2014 [Member]
Stockholders' Equity [Line Items]
Aggregate Common Stock Purchased					$ 15,000,000
Aspire Capital Fund, LLC 2015 [Member]
Stockholders' Equity [Line Items]
Commitment Shares Issued During Period					45,000
Preferred Tracking Stock [Member]
Stockholders' Equity [Line Items]
Stock Issued During Period, Value, New Issues														$ 13,000,000
Preferred Stock, Dividend Rate, Percentage																	2.00%
Dividends Payable						$ 350,000											$ 416,000
Convertible Preferred Stock, Shares Issued upon Conversion														29,990,000
Preferred Stock, Par or Stated Value Per Share														$ 0.001
Noncontrolling Interest, Ownership Percentage by Parent													9.99%	99.99%
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners														0.01%
iBio CDMO [Member] \| Eastern Share Purchase Agreements [Member]
Stockholders' Equity [Line Items]
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners				40.00%
Lincoln Park Capital Fund, LLC [Member]
Stockholders' Equity [Line Items]
Aggregate Common Stock Purchased													$ 16,000,000
Stock Issued During Period, Shares, New Issues										60,000			250,000
Stock Issued During Period, Value, New Issues										$ 121,290			$ 1,000,000
Share Price													$ 4.00
Maximum [Member] \| Lincoln Park Purchase Agreement [Member]
Stockholders' Equity [Line Items]
Aggregate Common Stock Purchased													$ 1,000,000